UK-500,001, a potent selective inhibitor of phosphodiesterase type 4 (PDE4) designed for inhaled delivery, inhibits TNF-a, MIP-1b and LTB4 released from native blood cells.
暂无分享,去创建一个
M. Trevethick | A. Barnard | M. Yeadon | S. Ballard | C. Perros-Huguet | G. Salmon | G. Sims | K. Banner | C. Brown | A. Lewis | F. Mansfield | N. Clark